What is Comera Life Sciences Holdings, Inc. (CMRA)?

Comera Life Sciences Holdings, Inc. (CMRA) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of CMRA?

The current price of CMRA is $0.00. Prices are updated in real time on Stocks360.

What is CMRA's price-to-earnings (PE) ratio?

CMRA's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is CMRA's market capitalization?

CMRA's market capitalization is $3,074.00, placing it in the small-cap tier.

Comera Life Sciences Holdings, Inc. (CMRA)

Stock analysis · OTC · Healthcare · Biotechnology

$0.00

Market Cap

$3.07K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.92

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

191.00

Comera Life Sciences Holdings, Inc. (CMRA) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $3.07K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.00 2026-10-28 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.